Guangxi Wuzhou Zhongheng Group Co Ltd (600252) - Total Liabilities
Based on the latest financial reports, Guangxi Wuzhou Zhongheng Group Co Ltd (600252) has total liabilities worth CN¥3.65 Billion CNY (≈ $534.68 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Guangxi Wuzhou Zhongheng Group Co Ltd - Total Liabilities Trend (1997–2025)
This chart illustrates how Guangxi Wuzhou Zhongheng Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Guangxi Wuzhou Zhongheng Group Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Guangxi Wuzhou Zhongheng Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guangxi Wuzhou Zhongheng Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tianjin Benefo Tejing Electric Co Ltd
SHG:600468
|
China | CN¥1.77 Billion |
|
Cybrid Technologies Inc
SHG:603212
|
China | CN¥1.61 Billion |
|
Montnets Cloud Technology Group Co Ltd
SHE:002123
|
China | CN¥1.65 Billion |
|
Zhejiang Dehong Automotive
SHG:603701
|
China | CN¥850.52 Million |
|
Taiwan Semiconductor Co Ltd
TWO:5425
|
Taiwan | NT$10.21 Billion |
|
MA Financial Group Ltd
AU:MAF
|
Australia | AU$8.06 Billion |
|
Inwido AB
ST:INWI
|
Sweden | Skr5.41 Billion |
|
Akasha Wira International Tbk
JK:ADES
|
Indonesia | Rp516.28 Billion |
Liability Composition Analysis (1997–2025)
This chart breaks down Guangxi Wuzhou Zhongheng Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Guangxi Wuzhou Zhongheng Group Co Ltd market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.69 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangxi Wuzhou Zhongheng Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangxi Wuzhou Zhongheng Group Co Ltd (1997–2025)
The table below shows the annual total liabilities of Guangxi Wuzhou Zhongheng Group Co Ltd from 1997 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥3.32 Billion ≈ $486.28 Million |
-4.07% |
| 2024-12-31 | CN¥3.46 Billion ≈ $506.93 Million |
+2.22% |
| 2023-12-31 | CN¥3.39 Billion ≈ $495.94 Million |
-2.12% |
| 2022-12-31 | CN¥3.46 Billion ≈ $506.67 Million |
+8.20% |
| 2021-12-31 | CN¥3.20 Billion ≈ $468.25 Million |
-14.60% |
| 2020-12-31 | CN¥3.75 Billion ≈ $548.28 Million |
+160.63% |
| 2019-12-31 | CN¥1.44 Billion ≈ $210.37 Million |
+9.78% |
| 2018-12-31 | CN¥1.31 Billion ≈ $191.63 Million |
+3.37% |
| 2017-12-31 | CN¥1.27 Billion ≈ $185.38 Million |
+8.84% |
| 2016-12-31 | CN¥1.16 Billion ≈ $170.33 Million |
-0.96% |
| 2015-12-31 | CN¥1.18 Billion ≈ $171.99 Million |
-44.25% |
| 2014-12-31 | CN¥2.11 Billion ≈ $308.52 Million |
-10.99% |
| 2013-12-31 | CN¥2.37 Billion ≈ $346.61 Million |
+52.31% |
| 2012-12-31 | CN¥1.56 Billion ≈ $227.56 Million |
-17.88% |
| 2011-12-31 | CN¥1.89 Billion ≈ $277.10 Million |
+16.11% |
| 2010-12-31 | CN¥1.63 Billion ≈ $238.65 Million |
+75.81% |
| 2009-12-31 | CN¥927.63 Million ≈ $135.74 Million |
+55.56% |
| 2008-12-31 | CN¥596.33 Million ≈ $87.26 Million |
-16.84% |
| 2007-12-31 | CN¥717.08 Million ≈ $104.93 Million |
+1.82% |
| 2006-12-31 | CN¥704.26 Million ≈ $103.06 Million |
-42.62% |
| 2005-12-31 | CN¥1.23 Billion ≈ $179.60 Million |
-5.51% |
| 2004-12-31 | CN¥1.30 Billion ≈ $190.08 Million |
+98.17% |
| 2003-12-31 | CN¥655.48 Million ≈ $95.92 Million |
+84.24% |
| 2002-12-31 | CN¥355.77 Million ≈ $52.06 Million |
+23.98% |
| 2001-12-31 | CN¥286.96 Million ≈ $41.99 Million |
+37.49% |
| 2000-12-31 | CN¥208.72 Million ≈ $30.54 Million |
+15.56% |
| 1999-12-31 | CN¥180.62 Million ≈ $26.43 Million |
-5.90% |
| 1998-12-31 | CN¥191.95 Million ≈ $28.09 Million |
+2.51% |
| 1997-12-31 | CN¥187.24 Million ≈ $27.40 Million |
-- |
About Guangxi Wuzhou Zhongheng Group Co Ltd
Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for … Read more